EMILY REDMOND: Open Payments
NPI 1841397395 · OVERLAND PARK, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,408 in 64 payments from 13 companies in 2025. Trend: 2023 $1,026 · 2024 $2,011 · 2025 $1,408
Food & beverage: $1,333Education: $75
| Company | Payments | Amount |
|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES INC. | 10 | $256 |
| Novartis Pharmaceuticals Corporation | 5 | $242 |
| ABBVIE INC. | 14 | $212 |
| Galderma Laboratories, L.P. | 12 | $187 |
| Janssen Biotech, Inc. | 4 | $142 |
| UCB, Inc. | 3 | $82 |
| Amgen Inc. | 4 | $70 |
| Arcutis Biotherapeutics, Inc. | 4 | $69 |
| PFIZER INC. | 3 | $53 |
| Lilly USA, LLC | 2 | $45 |
Products named: ILUMYA, RINVOQ, NEMLUVIO, TREMFYA, Rhapsido, COSENTYX, Bimzelx, OTEZLA.
Industry payments across KS — which companies pay providers there.
